Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

206 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines.
Hollestelle A, Nagel JH, Smid M, Lam S, Elstrodt F, Wasielewski M, Ng SS, French PJ, Peeters JK, Rozendaal MJ, Riaz M, Koopman DG, Ten Hagen TL, de Leeuw BH, Zwarthoff EC, Teunisse A, van der Spek PJ, Klijn JG, Dinjens WN, Ethier SP, Clevers H, Jochemsen AG, den Bakker MA, Foekens JA, Martens JW, Schutte M. Hollestelle A, et al. Among authors: ten hagen tl. Breast Cancer Res Treat. 2010 May;121(1):53-64. doi: 10.1007/s10549-009-0460-8. Epub 2009 Jul 11. Breast Cancer Res Treat. 2010. PMID: 19593635
Association of TIMP3 expression with vessel density, macrophage infiltration and prognosis in human malignant melanoma.
Das AM, Koljenović S, Oude Ophuis CM, van der Klok T, Galjart B, Nigg AL, van Cappellen WA, Noordhoek Hegt V, Dinjens WN, Atmodimedjo PN, Vermeulen CE, Verhoef C, Eggermont AM, ten Hagen TL. Das AM, et al. Among authors: ten hagen tl. Eur J Cancer. 2016 Jan;53:135-43. doi: 10.1016/j.ejca.2015.09.014. Epub 2015 Dec 17. Eur J Cancer. 2016. PMID: 26707830
Tissue inhibitor of metalloproteinase-3 (TIMP3) expression decreases during melanoma progression and inhibits melanoma cell migration.
Das AM, Bolkestein M, van der Klok T, Oude Ophuis CM, Vermeulen CE, Rens JA, Dinjens WN, Atmodimedjo PN, Verhoef C, Koljenović S, Smits R, Ten Hagen TL, Eggermont AM. Das AM, et al. Among authors: ten hagen tl. Eur J Cancer. 2016 Oct;66:34-46. doi: 10.1016/j.ejca.2016.06.020. Epub 2016 Aug 11. Eur J Cancer. 2016. PMID: 27522248
Cell membrane modulation as adjuvant in cancer therapy.
Zalba S, Ten Hagen TL. Zalba S, et al. Among authors: ten hagen tl. Cancer Treat Rev. 2017 Jan;52:48-57. doi: 10.1016/j.ctrv.2016.10.008. Epub 2016 Nov 9. Cancer Treat Rev. 2017. PMID: 27889637 Free PMC article. Review.
206 results